The facts that Act1 expression is increased in colon epithelial cells in mice with IBD and Act1-deficient mice show a delayed onset and much lower severity of DSS-induced colitis [19] suggest that Act1 is involved in the regulation of IBD, but whether or how it is involved in IL-17A-mediated negative regulation remained to be investigated. This evidence concerns the gene IL17A and inflammatory bowel disease.